Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01953874 · ClinicalTrials.gov registry record · NA
Cardiovascular Improvements With MV ASV Therapy in Heart Failure
A NA study, sponsored by ResMed.
- Terminated
- Registry status
- NA
- Development phase
- 126
- Enrollment target
NCT01953874: Clinical Trial NA study, sponsored by ResMed.
NCT01953874 is a NA study that was terminated before completion, run by ResMed. The registered enrollment target is 126 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01953874, a NA study, was terminated before completion, sponsored by ResMed.
- TERMINATED
- Registry status
- NA
- Development phase
- 126 participants
- Enrollment target
Study Summary
The aim of the study is to compare the effects of MV targeted ASV in addition to optimized medical therapy versus optimized medical therapy alone at 6 months in patients with acute decompensated HF. The study will also assess changes in functional parameters, biomarkers, quality of life (QOL), and sleep.
Primary Outcome
A rank order response based on survival free from CV hospitalization and improvement in functional capacity measured by 6MWD. All participants were first ranked by time to death, then ranked by time to CV hospitalization, and then ranked by percentage change in 6MWD. For time to event measures (time to death and time to hospitalization), the shorter the amount of time, the lower the rank assigned to that participant. For percentage changes in 6MWD, the smaller the percentage change, the lower th
Interventions
- DRUG Optimized Medical Treatment
- DEVICE MV ASV
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2013-12 |
| Est. Completion | 2015-12 |
| Phase | NA |
Why NCT01953874 stopped before completion
NCT01953874 is an interventional study that assigns participants to a tested intervention. The registered 126 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 2 interventions - of which Optimized Medical Treatment is the first listed.
NCT01953874 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01953874 about?
NCT01953874 is a clinical study titled "Cardiovascular Improvements With MV ASV Therapy in Heart Failure". The aim of the study is to compare the effects of MV targeted ASV in addition to optimized medical therapy versus optimized medical therapy alone at 6 months in patients with acute decompensated HF. The study will also assess changes in functional parameters, biomarkers, quality of life (QOL), and s...
What is the current status of trial NCT01953874?
This trial is currently terminated. It is a NA study. The enrollment target is 126 participants. The study started on 2013-12. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01953874?
The interventions under investigation include: Optimized Medical Treatment (DRUG), MV ASV (DEVICE).
Who is sponsoring clinical trial NCT01953874?
This trial is sponsored by ResMed, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01953874's enrollment target sits among peer trials
126 749th of 2000 higher than 1,248 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01873131 · 126 participants · NA
A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn
- NCT02621645 · 126 participants · Phase 4
TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence
- NCT03838107 · 126 participants
Markers of Trajectory in Pediatric CRPS
- NCT03906422 · 126 participants · NA
Comparison of Patient-reported Pain After Initial Archwire Placement
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia